Mutagenic and epigenetic effects of DNA methylation

Mutation Research - Reviews in Mutation Research

Volumn 386, Issue 2, 1997, Pages 107-118

  Gonzalgo, Mark L ^a   Jones, Peter A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

DNA methylation; DNA methyltransferase; p16; p53; Transition mutation; Tumor suppressor gene

Indexed keywords

5 METHYLCYTOSINE; DNA METHYLTRANSFERASE;

CARCINOGENESIS; CELL CYCLE; DEAMINATION; DNA METHYLATION; GENE EXPRESSION; HUMAN; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0030902720     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(96)00047-6     Document Type: Review

References (78)

1. Nowell, P.C. (1976) The clonal evolution of tumor cell populations, Science, 194, 23-28.
2. Feinberg, A.P. and B. Vogelstein (1983) Hypomethylation distinguishes genes of some human cancers from their normal counterparts, Nature, 301, 89-92.
3. Gama-Sosa, M.A., V.A. Slagel, R.W. Trewyn, R. Oxenhandler, K.C. Kuo, C.W. Gehrke and M. Ehrlich (1983) The 5-methylcytosine content of DNA from human tumors, Nucleic Acids Res., 11, 6883-6894.
4. Jones, P.A. (1986) DNA methylation and cancer, Cancer Res., 46, 461-466.
5. Bird, A.P. (1992) The essentials of DNA methylation, Cell, 70, 5-8.
6. Li, E., T. Bestor and R. Jaenisch (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality, Cell, 69, 915-926.
7. Clark, S.J., J. Harrison and M. Frommer (1995) CpNpG methylation in mammalian cells, Nature Genet., 10, 20-27.
8. Schorderet, D.F. and S.M. Gartler (1992) Analysis of CpG suppression in methylated and nonmethylated species, Proc. Natl. Acad. Sci. USA, 89, 957-961.
9. Lindahl, T. and B. Nyberg (1974) Heat-induced deamination of cytosine residues in deoxyribonucleic acid, Biochemistry, 13, 3405-3410.
10. Sved, J. and A. Bird (1990) The expected equilibrium of the CpG dinucleotide in vertebrate genomes under a mutation model, Proc. Natl. Acad. Sci. USA, 87, 4692-4696.
11. Shen, J.-C., W.M. Rideout III and P.A. Jones (1992) High frequency mutagenesis by a DNA methyltransferase, Cell, 71, 1073-1080.
12. Bird, A.P. (1986) CpG-rich islands and the function of DNA methylation, Nature, 321, 209-213.
13. Gardiner-Garden, M. and M. Frommer (1987) CpG islands in vertebrate genomes, J. Mol. Biol., 196, 261-282.
14. Cedar, H. (1988) DNA methylation and gene activity, Cell, 53, 3-4.
15. Riggs, A.D. and G.P. Pfeifer (1992) X-chromosome inactivation and cell memory, Trends. Genet., 8, 169-174.
16. Bartolomei, M.S., S. Zemel and S.M. Tilghman (1991) Parental imprinting of the mouse H19 gene, Nature, 351, 153-155.
17. Ferguson-Smith, A., H. Sasaki, B.M. Cattanach and M.A. Surani (1993) Parental-origin-specific epigenetic modification of the mouse H19 gene, Nature, 362, 751-755.
18. Coulondre, C., J.H. Miller, P.J. Farabaugh and W. Gilbert (1978) Molecular basis of base substitution hotspots in Escherchia coli, Nature, 274, 775-780.
19. Rideout, W.M. III., G.A. Coetzee, A.F. Olumi and P.A. Jones (1990) 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes, Science, 249, 1288-1290.
20. Cooper, D.N. and H. Youssoufian (1988) The CpG dinucleotide and human genetic disease, Hum. Genet., 78, 151-155.
21. Yang, A.S., M.L. Gonzalgo, J.-M. Zingg, R.P. Millar, J.D. Buckley and P.A. Jones (1996) The rate of CpG mutation in Alu repetitive elements within the p53 tumor suppressor gene in the primate germline, J. Mol. Biol., 258, 240-250.
22. Shen, J.-C., W.M. Rideout III and P.A. Jones (1994) The rate of hydrolytic deamination of 5-methylcytosine in double-stranded DNA, Nucleic Acids Res., 22, 972-976.
23. Mol, C.D., A.S. Arvai, G. Slupphaug, B. Kavli, I. Alseth, H.E. Krokan and J.A. Tainer (1995) Crystal structure and mutational analysis of human uracil-DNA glycosylase: structural basis for specificity and catalysis, Cell, 80, 869-878.
24. Shenoy, S., K.C. Ehrlich and M. Ehrlich (1987) Repair of thymine • guanine and uracil • guanine mismatched base-pairs in bacteriophage M13mp18 DNA heteroduplexes, J. Mol. Biol., 197, 617-626.
25. Schmutte, C., A.S. Yang, R.W. Beart and P.A. Jones (1995) Base excision repair of U:G mismatches at a mutational hotspot in the p53 gene is more efficient than base excision repair of T:G mismatches in extracts of human colon tumors, Cancer Res., 55, 3742-3746.
26. Ehrlich, M., K.F. Norris, R. Y.-H. Wang, K.C. Kuo and C.W. Gehrke (1986) DNA cytosine methylation and heat-induced deamination, Biosci. Rep., 6, 387-393.
27. Cooper, D.N. and M. Krawczak (1989) Cytosine methylation and the fate of CpG dinucleotides in vertebrate genomes, Hum. Genet., 83, 181-188.
28. Koeberl, D.D., C.D.K. Bottema, R.P. Ketterling, P.J. Bridge, D.P. Lillicrap and S.S. Sommer (1990) Mutations causing hemophilia B: direct estimate of the underlying rates of spontaneous germ-line transitions, transversions, and deletions in a human gene, Am. J. Hum. Genet., 47, 202-217.
29. Jurka, J. and A. Milosavljevic (1991) Reconstruction and analysis of human Alu genes, J. Mol. Evol., 32, 105-121.
30. Shen, J.-C., J.-M. Zingg, A.S. Yang, C. Schmutte and P.A. Jones (1995) A mutant HpaII methyltransferase functions as a mutator enzyme, Nucleic Acids Res., 23, 4275-4282.
31. Wu, J.C. and D.V. Santi (1987) Kinetic and catalytic mechanism of HhaI methyltransferase, J. Biol. Chem., 262, 4778-4786.
32. Laird, P.W. and R. Jaenisch (1994) DNA methylation and cancer, Hum. Mol. Genet., 3, 1487-1495.
33. Yebra, M.J. and A.S. Bhagwat (1995) A cytosine methyltransferase converts 5-methylcytosine in DNA to thymine, Biochemistry, 34, 14752-14757.
34. Klimasauskas, S., S. Kumar, R.J. Roberts and X. Cheng (1994) HhaI methyltransferase flips its target base out of the DNA helix, Cell, 76, 357-369.
35. Klimasauskas, S. and R.J. Roberts (1995) M.HhaI binds tightly to substrates containing mismatches at the target base, Nucleic Acids Res., 23, 1388-1395.
36. Yang, A.S., J.-C. Shen, J.-M. Zingg, S. Mi and P.A. Jones (1995) HhaI and HpaII DNA methyltransferases bind DNA mismatches, methylate uracil and block DNA repair, Nucleic Acids Res., 23, 1380-1387.
37. Schmutte, C., A.S. Yang, T.T. Nguyen, R.W. Beart and P.A. Jones (1996) Mechanisms for the involvement of DNA methylation in colon carcinogenesis, Cancer Res., 56, 2375-2381.
38. Issa, J.-P., P.M. Vertino, J. Wu, S. Sazawal, P. Celano, B.D. Nelkin, S.R. Hamilton and S.B. Baylin (1993) Increased cytosine DNA-methyltransferase activity during colon cancer progression, J. Natl. Cancer Inst, 85, 1235-1240.
39. El-Deiry, W.S., B.D. Nelkin, P. Celano, R.W. Yen, J.P. Falco, S.R. Hamilton and S.B. Baylin (1991) High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer, Proc. Natl. Acad. Sci. USA, 88, 3470-3474.
40. Szyf, M., F. Kaplan, V. Mann, et al. (1985) Cell cycle-dependent regulation of eukaryotic DNA methylase level, J. Biol. Chem., 260, 8653-8656.
41. Greenblatt, M.S., W.P. Bennett, M. Hollstein and C.C. Harris (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis, Cancer Res., 54, 4855-4878.
42. Magewu, A.N. and P.A. Jones (1994) Ubiquitous and tenacious methylation of the CpG site in codon 248 of the p53 gene may explain its frequent appearance as a mutational hotspot in human cancer, Mol. Cell Biol., 14, 4225-4232.
43. Tornaletti, S.P. and G.P. Pfeifer (1995) Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers, Oncogene, 10, 1493-1499.
44. Yang, A.S., A. Shibata and P.A. Jones (1996b) The mutational burden of 5-methylcytosine, in: V.E.A. Russo, R. Martienssen and A. Riggs (Eds.), Epigenetics, Cold spring harbor laboratory press, New York, pp. 77-94.
45. Kamb, A., N.A. Gruis, J. Weaver-Feldhaus, Q. Liu, K. Harshman, S.V. Tavtigian, E. Stockert, R.S. Day III, B.E. Johnson and M.H. Skolnick. (1994) A cell cycle regulator potentially involved in genesis of many tumor types, Science, 264, 436-440.
46. Nobori, T., K. Miura, D.J. Wu, A. Lois, K. Takabayashi and D.A. Carson (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers, Nature, 368, 753-756.
47. Pollock, P.M., F. Yu, L. Qiu, P.G. Parsons and N.K. Hayward (1995) Evidence for u.v. induction of CDKN2 mutations in melanoma cell lines, Oncogene, 11, 663-668.
48. Pollock, P.M., J.V. Pearson and N.K. Hayward (1996) Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions, Genes Chrom. Cancer, 15, 77-88.
49. Gonzalez-Zulueta, M., C.M. Bender, A.S. Yang, T. Nguyen, R.W. Beart, J.M. Van Tornout and P.A. Jones (1995) Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing, Cancer Res., 55, 4531-4535.
50. Laird, P.W., L. Jackson-Grusby, A. Fazeli, S.L. Dickinson, W.E. Jung, E. Li, R.A. Weinberg and R. Jaenisch (1995) Suppression of intestinal neoplasia by DNA hypomethylation, Cell, 81, 197-205.
51. Counts, J.L. and J.I. Goodman (1994) Hypomethylation of DNA: an epigenetic mechanism involved in tumor promotion, Mol. Carcinogen., 11, 185-188.
52. Goelz, S.E., B. Vogelstein, S.R. Hamilton and A.P. Feinberg (1985) Hypomethylation of DNA from benign and malignant human colon neoplasms, Science, 228, 187-190.
53. Wolf, S.F., D.J. Jolly, K.D. Lunnen, T. Friedmann and B.R. Migeon (1984) Methylation of the hypoxanthine phosphoribosyltransferase locus on the human X chromosome: implications for X chromosome inactivation, Proc. Natl. Acad. Sci. USA, 81, 2806-2810.
54. Toniolo, D., G. Martini, B.R. Migeon and R. Dono (1988) Expression of the G6PD locus on the human X chromosome is associated with demethylation of three CpG islands within 100 kb of DNA, EMBO J., 7, 401-406.
55. Pfeifer, G.P., R.L. Tanguay, S.D. Steigerwald and A.D. Riggs (1990) In vivo footprint and methylation analysis by PCR-aided genomic sequencing: comparison of active and inactive X chromosomal DNA at the CpG island and promoter of human PGK-1, Genes Dev., 4, 1277-1287.
56. Hansen, R.S. and S.M. Gartler (1990) 5-Azacytidine-induced reactivation of the human X chromosome-linked PGK1 gene is associated with a large region of cytosine demethylation in the 5′ CpG island, Proc. Natl. Acad. Sci. USA, 87, 4174-4178.
57. Antequera, F., J. Boyes and A. Bird (1990) High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines, Cell, 62, 503-514.
58. Jones, P.A., M.J. Wolkowicz, W.M. Rideout III, F.A. Gonzales, C.M. Marziasz, G.A. Coetzee and S.J. Tapscott (1990) De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines, Proc. Natl. Acad. Sci. USA, 87, 6117-6121.
59. Rideout, W.M. III., P. Eversole-Cire, C.H. Spruck III, C.M. Hustad, G.A. Coetzee, F.A. Gonzales and P.A. Jones (1994) Progressive increases in the methylation status and heterochromatinization of the myoD CpG island during oncogenic transformation, Mol. Cell. Biol., 14, 6143-6152.
60. Michalowsky, L.A. and P.A. Jones (1989) Gene structure and transcription in mouse cells with extensively demethylated DNA, Mol. Cell. Biol., 9, 885-892.
61. Lee, Y.-W., C.B. Klein, B. Kargacin, K. Salnikow, J. Kitahara, K. Dowjat, A. Zhitkovich, N.T. Christie and M. Costa (1995) Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens, Mol. Cell Biol., 15, 2547-2557.
62. Levine, A., G.L. Cantoni and A. Razin (1992) Methylation in the preinitiation domain suppresses gene transcription by an indirect mechanism, Proc. Natl. Acad. Sci. USA, 89, 10119-10123.
63. Meehan, R.R., J.D. Lewis, S. McKay, E.L. Kleiner and A.P. Bird (1989) Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs, Cell, 58, 499-507.
64. Boyes, J. and A. Bird (1991) DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein, Cell, 64, 1123-1134.
65. Hsieh, C.-L. (1994) Dependence of transcriptional repression on CpG methylation density, Mol. Cell. Biol., 14, 5487-5494.
66. Robertson, K.D., S.D. Hayward, P.D. Ling, D. Samid and R.F. Ambinder (1995) Transcriptional activation of the epstein-barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial, Mol. Cell Biol., 15, 6150-6159.
67. Greger, V., E. Passarge, W. Hopping, E. Messmer and B. Horsthemke (1989) Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma, Hum. Genet., 83, 155-158.
68. Sakai, T., J. Toguchida, N. Ohtani, D.W. Yandell, J.M. Rapaport and T.P. Dryja (1991) Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene, Am. J. Hum. Genet., 48, 880-888.
69. Ohtani-Fujita, N., T. Fujita, A. Aoike, N.B. Osifchin, P.D. Robbins and T. Sakai (1993) CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene, Oncogene, 8, 1063-1067.
70. Gnarra, J.R., K. Tory and Y. Weng (1994) Mutations of the VHL tumour suppressor gene in renal carcinoma, Nature Genet., 7, 85-90.
71. Herman, J.G., F. Latif, Y. Weng, M.I. Lerman, B. Zbar, S. Liu, D. Samid, D.S. Duan, J.R. Gnarra, W.M. Linehan and S.B. Baylin (1994) Silencing of the VHL tumor-suppressor gene by DNA methylation in renal cell carcinoma, Proc. Natl. Acad. Sci. USA, 91, 9700-9704.
72. Cairns, P., L. Mao, A. Merlo,. D.J. Lee, D. Schwab, Y. Eby, K. Tokino, P. van der Riet, J.E. Blaugrund and D. Sidransky (1994) Rates of p16 (MTS1) mutations in primary tumors with 9p loss, Science, 265, 415-417.
73. Spruck, C.H. III, M. Gonzalez-Zulueta, A. Shibata, A.R. Simoneau, M.-F. Lin, F. Gonzales, Y.C. Tsai and P.A. Jones (1994) p16 gene in uncultured tumours, Nature, 370, 183-184.
74. Herman, J.G., A. Merlo, L. Mao, R.G. Lapidus, J.-P. Issa, N.E. Davidson, D. Sidransky and S.B. Baylin (1995) Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers, Cancer Res., 55, 4525-4530.
75. Merlo, A., J.G. Herman, L. Mao, D.J. Lee, E. Gabrielson, P.C. Burger, S.B. Baylin and D. Sidransky (1995) 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers, Nature Med., 1, 686-692.
76. Bender, C., M. Gonzalez-Zulueta, M.M. Pao, J.M. Zingg, Y.C. Tsai and P.A. Jones. Activation of a dormant p16/CDKN2 tumor suppressor gene by 5-aza-2′-deoxycytidine restores growth control to human bladder cancer cells, manuscript in preparation.
77. Hao, Y., T. Crenshaw, T. Moulton, E. Newcomb and B. Tycko (1993) Tumour-suppressor activity of H19 RNA, Nature, 365, 764-767.
78. Steenman, M.J.C., S. Rainier, C.J. Dobry, P. Grundy, I.L. Horon and A.P. Feinberg (1994) Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumor, Nature Genet., 7, 433-439.